This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gronski, J.R., Seiler, F.R. & Schwick, H.G. Discovery of antitoxins and development of antibody preparations for clinical uses from 1890 to 1990. Molec. Immun. 28, 1321–1332 (1991).
Barbas, C.F., Bain, J.D., Hoekstra, D.M. & Lerner, R.A. Semi-synthetic combinatorial antibody libraries: A chemical solution to the diversity problem. Proc. natn. Acad. Sci. U.S.A. 89, 4457–4461 (1992).
Padlan, E.A. Anatomy of the antibody molecule. Molec. Immun. 31, 169–217 (1994).
Sanz, I. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J. Immun. 147, 1720–1729 (1991).
Wu, T.T., Johnson, G. & Kabat, E.A. Length distribution of CDRH3 in antibodies. Proteins Struct. Funct. Genet. 16, 1–7 (1993).
Barre, S. et al. Structural conservation of hyper-variable regions in immunoglobulin evolution. Nature struct. Biol. 1, 915–920 (1994).
Burton, D.R. & Barbas, C.F. Human antibodies from combinatorial libraries. Adv. Immun. 57, 191–280 (1994).
Barbas, S.M. & Barbas, C.F. Filamentous phage display. Fibrinolysis 8, 245–252 (1994).
Lerner, R.A., Kang, A.S., Bain, J.D., Burton, D.R. & Barbas, C.F. Antibodies without immunization. Science 258, 1313–1314 (1992).
Barbas, C.F. & Wagner, J. Synthetic human antibodies: Selecting and evolving functional proteins. Meth. Companion Meth. Enzym. (in the press).
Akamatsu, Y., Cole, M.S. et al. Construction of a human Ig combinatorial library from genomic V segments and synthetic CDR3 fragments. J. Immun. 15, 4651–4659 (1993).
De Kruif, J. et al. Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions. J. molec. Biol. 248, 97–105 (1995).
Barbas, C.F., Amberg, W., Somincsits, A., Jones, T.M. & Lerner, R.A. Selection of human antihapten antibodies from semisynthetic libraries. Gene 137, 57–62 (1993).
Barbas, C.F., Languino, L.R. & Smith, J.W. High affinity self-reactive human antibodies by design and selection: Targeting the integrin ligand binding site. Proc. natn. Acad. Sci. U.S.A. 90, 10003–10007 (1993).
Smith, J.W., Hu, D., Satterthwait, A.C., PinzSweeney, S. & Barbas, C.F. Building synthetic antibodies as adhesive ligands for integrins. J. biol. Chem. 269, 32788–32795 (1994).
Topol, E.J. et al. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restanosis: Results at six months. Lancet 343, 881–886 (1994).
Brooks, P.C., Clark, R.A.F. & Cheresh, D.A. Requirement of vascular integrin avb3 for angiogenesis. Science 264, 569–571 (1994).
Garrard, L.J. & Henner, D.J. Selection of an anti-IGF-1 fab from a fab phage library created by mutagenesis of multiple CDR loops. Gene 128, 103–109 (1993).
Barbas, C.F., Rosenblum, J.S. & Lerner, R.A. Direct selection of antibodies which coordinate metals from semisynthetic combinatorial libraries. Proc. natn. Acad. Sci. U.S.A. 14, 6385–6389 (1993).
Hoogenboom, H.R. & Winter, G. By-passing immunization human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro . J. molec. Biol. 227, 381–388 (1992).
Griffiths, A.D. et al. Human anti-self antibodies with high specificity from phage display libraries. EMBO J. 12, 725–734 (1993).
Griffiths, A.D. et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13, 3245–3260 (1994).
Karu, A.E. et al. Recombinant antibodies to small analytes and prospects for deriving them from synthetic combinatorial libraries. Food agric. Immun. 6, 277–286 (1994).
Barbas, S.M., Ghazal, P., Barbas, C.F. & Burton, D.R. Recognition of DNA by synthetic antibodies. J. Am. chem. Soc. 116, 2161–2162 (1994).
De Kruif, J. et al. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc. natn. Acad. Sci. U.S.A. 92, 3938–3942 (1995).
Janda, K.D., Lo, C.-H.L., Li, T., Barbas, C.F., Wirsching, P. & Lerner, R.A. Direct selection for a catalytic mechanism from combinatorial antibody libraries. Proc. natn. Acad. Sci. U.S.A. 91, 2532–2536 (1994).
Marks, J.D. et al. By-passing immunization: Building high affinity human antibodies by chain shuffling. Bio/Technology 10, 779–783 (1992).
Barbas, C.F. et al. In vitroevolution of a neutralizing human antibody to HIV-I to enhance affinity and broaden strain cross-reactivity. Proc. natn. Acad. Sci. U.S.A. 91, 3809–3813 (1994).
Pack, P. et al. Tetravalent miniantibodies with high avidity assembling in Escherichia coli . J. molec. Biol. 248, 29–34 (1995).
Crowe, J.E. Jr, et al. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc. natn. Acad. Sci. U.S.A. 91, 2133–2137 (1994).
Burton, D.R. et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024–1026 (1994).
Ridder, R., Schmitz, R., Legay, F. & Gram, H. Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris . Bio/Technology 13, 255–260 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barbas, C. Synthetic human antibodies. Nat Med 1, 837–839 (1995). https://doi.org/10.1038/nm0895-837
Issue Date:
DOI: https://doi.org/10.1038/nm0895-837
This article is cited by
-
Generation of a Recombinant Full-Length Human Antibody Binding to Botulinum Neurotoxin A
Applied Biochemistry and Biotechnology (2010)
-
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
Nature Chemical Biology (2009)
-
Engineering antibody Fv fragments for cancer detection and therapy: Bisulfide-stabilized Fv fragments
Nature Biotechnology (1996)
-
Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial library
Nature Medicine (1996)